Clinical Characteristics, Effectiveness and Safety Outcomes in Chinese Patients With Chronic Kidney Disease and Type 2 Diabetes Who Initiated Finerenone: A Retrospective Real‐World Cohort Study From the <scp>FOUNTAIN</scp> Platform

Yan Kong, Bei Sun, Chunyan Shan, Zhe Xu, Hui Yang, Nikolaus G. Oberprieler, Huan Wei, Liming Chen

Open source

DOI
10.1111/dom.71531
Published
2026-11-08
Container
Diabetes, Obesity and Metabolism
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71531,
  title = {Clinical Characteristics, Effectiveness and Safety Outcomes in Chinese Patients With Chronic Kidney Disease and Type 2 Diabetes Who Initiated Finerenone: A Retrospective Real‐World Cohort Study From the
                    <scp>FOUNTAIN</scp>
                    Platform},
  author = {Yan Kong and Bei Sun and Chunyan Shan and Zhe Xu and Hui Yang and Nikolaus G. Oberprieler and Huan Wei and Liming Chen},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71531},
  url = {https://doi.org/10.1111/dom.71531}
}

RIS

TY  - JOUR
TI  - Clinical Characteristics, Effectiveness and Safety Outcomes in Chinese Patients With Chronic Kidney Disease and Type 2 Diabetes Who Initiated Finerenone: A Retrospective Real‐World Cohort Study From the
                    <scp>FOUNTAIN</scp>
                    Platform
AU  - Yan Kong
AU  - Bei Sun
AU  - Chunyan Shan
AU  - Zhe Xu
AU  - Hui Yang
AU  - Nikolaus G. Oberprieler
AU  - Huan Wei
AU  - Liming Chen
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71531
UR  - https://doi.org/10.1111/dom.71531
ER  - 

APA

Kong, Y., Sun, B., Shan, C., Xu, Z., Yang, H., Oberprieler, N. G., Wei, H., & Chen, L. (2026). Clinical Characteristics, Effectiveness and Safety Outcomes in Chinese Patients With Chronic Kidney Disease and Type 2 Diabetes Who Initiated Finerenone: A Retrospective Real‐World Cohort Study From the <scp>FOUNTAIN</scp> Platform. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71531

Source records